Nicholas R. Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicholas R. Nelson has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Denise H. Rhoney
UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC
15 shared publications - Aleda M. H. Chen
College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
8 shared publications - Cindy D. Stowe
University of Arkansas for Medical Sciences College of Pharmacy, 4301 W. Markham St. #522, Little Rock, AR 72205
7 shared publications Dennis Parker
Euguene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI, 48201, USA
7 shared publications- Kimberley K. Daugherty
Sullivan University
7 shared publications - Krisy-Ann Thornby
Professor of Pharmacy Practice, Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, 901 S. Flagler Drive, West Palm Beach. FL 33416
7 shared publications
Latest Publications
- 22 July 2026
- Published by Taylor & Francis in Medical Teacher
- p. 1-8
Development and initial validation of a practical instrument supporting clinical reasoning and self-directed learning
Practice pointsHistoric instruments for measuring metacognitive traits are not comprehensive and lack validation in clinical reasoning contexts. This limits their practical use by health profession...
- 22 July 2026
- Published by Taylor & Francis in Medical Teacher
- p. 1-8
Development and initial validation of a practical instrument supporting clinical reasoning and self-directed learning
Practice pointsHistoric instruments for measuring metacognitive traits are not comprehensive and lack validation in clinical reasoning contexts. This limits their practical use by health profession...
- Open Access
- 18 June 2026
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (11) , 1023-1034
Identifying stakeholder behaviors for competency-based pharmacy education: A stage 1 behavior change wheel analysis
- 18 June 2026
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (11) , 1023-1034
Open AccessIdentifying stakeholder behaviors for competency-based pharmacy education: A stage 1 behavior change wheel analysis
- 17 June 2026
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (5) , 103470
A bibliometric analysis describing the global scope of pharmacist roles (2000–2024)
- 17 June 2026
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (5) , 103470
A bibliometric analysis describing the global scope of pharmacist roles (2000–2024)
- 1 June 2026
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 9 (6) , e70232
A Bibliometric Analysis of Pharmacist‐Delivered Care: Global Trends, Outcomes, and Practice Settings (2000–2024)
Background: As the health care landscape evolves rapidly, the demand for an expanded role of pharmacists is also growing. There is ample literature documenting the positive health outcomes of pharmacist‐provided services, independently and in collaborative roles. Bibliometric analysis can aid researchers in understanding patterns within the literature, which could be useful in examining the reported outcomes and how pharmacy currently is and could evolve to meet society's needs. Thus, the objective of this study was to describe reported outcomes of pharmacist interventions in the literature from 2000 to 2024 by: (1) describing study characteristics, (2) mapping co‐occurrence networks of practice settings, (3) identifying commonly used terminology describing patient‐, population‐, and system‐level outcomes, and (4) comparing outcome differences in the top three practice settings. Methods: Using a bibliometric analytical design, a PubMed literature search focused on pharmacist‐related outcomes was conducted. The search results were imported to Covidence (Melbourne, Australia) for title and abstract screening, followed by categorization into preset outcome categories and subcategories. Included studies were analyzed descriptively to explain the scope, pattern, and common terms, while inferential statistics were used to compare differences between practice settings and outcomes. Results: From 6274 initial publications, 1010 were included, covering outcomes at the patient‐level (758; 75%), systems‐level (666; 65.9%), and population‐level (410; 40.6%). Ambulatory care, hospital, and community pharmacy were the top three practice settings identified. While there were varying co‐occurrences based on the practice setting, Clinical Outcomes, Medication Adherence/Compliance, and Patient Education/Patient Counseling were the three most common subcategories of outcomes published. Publications in the topic areas of Health Disparities/Health Equity and Immunization Rates have emerged in recent years. Conclusion: A bibliometric analysis of pharmacist‐related outcomes describes pharmacist involvement in outcome‐based practice at patient, system, and population levels. The research on pharmacist outcomes continues to grow and is clinically focused. Opportunities to address global and system‐level health needs remain.
- 1 June 2026
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 9 (6) , e70232
A Bibliometric Analysis of Pharmacist‐Delivered Care: Global Trends, Outcomes, and Practice Settings (2000–2024)
Background: As the health care landscape evolves rapidly, the demand for an expanded role of pharmacists is also growing. There is ample literature documenting the positive health outcomes of pharmacist‐provided services, independently and in collaborative roles. Bibliometric analysis can aid researchers in understanding patterns within the literature, which could be useful in examining the reported outcomes and how pharmacy currently is and could evolve to meet society's needs. Thus, the objective of this study was to describe reported outcomes of pharmacist interventions in the literature from 2000 to 2024 by: (1) describing study characteristics, (2) mapping co‐occurrence networks of practice settings, (3) identifying commonly used terminology describing patient‐, population‐, and system‐level outcomes, and (4) comparing outcome differences in the top three practice settings. Methods: Using a bibliometric analytical design, a PubMed literature search focused on pharmacist‐related outcomes was conducted. The search results were imported to Covidence (Melbourne, Australia) for title and abstract screening, followed by categorization into preset outcome categories and subcategories. Included studies were analyzed descriptively to explain the scope, pattern, and common terms, while inferential statistics were used to compare differences between practice settings and outcomes. Results: From 6274 initial publications, 1010 were included, covering outcomes at the patient‐level (758; 75%), systems‐level (666; 65.9%), and population‐level (410; 40.6%). Ambulatory care, hospital, and community pharmacy were the top three practice settings identified. While there were varying co‐occurrences based on the practice setting, Clinical Outcomes, Medication Adherence/Compliance, and Patient Education/Patient Counseling were the three most common subcategories of outcomes published. Publications in the topic areas of Health Disparities/Health Equity and Immunization Rates have emerged in recent years. Conclusion: A bibliometric analysis of pharmacist‐related outcomes describes pharmacist involvement in outcome‐based practice at patient, system, and population levels. The research on pharmacist outcomes continues to grow and is clinically focused. Opportunities to address global and system‐level health needs remain.
- 28 January 2026
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 9 (2) , e70177
Future‐Proofing Pharmacy: A Stakeholder‐Informed Forecast of Workforce and Education Needs
Background: Pharmacy education and workforce development are undergoing significant disruption. While national forecasts outline key directions, they lack granularity and stakeholder validation. This study aimed to develop a stakeholder‐informed, data‐driven forecast of pharmacy strategic priorities through 2035. Objectives were: (1) identify key themes shaping pharmacy's future, (2) align these themes with national priorities, and (3) forecast their trajectory and readiness to inform strategic planning. Methods: A mixed‐methods design integrated qualitative analysis of 27 stakeholder focus groups and eight interviews with trend modeling and policy triangulation. Participants ( n = 148) represented students, faculty, preceptors, administrators, professional organizations, payors, interprofessional educators, and transformation leaders. Transcripts were coded using grounded theory and analyzed for themes. Identified themes were aligned with the 2024 American Association of Colleges of Pharmacy and 2024 American Society of Health‐System Pharmacy Forecast reports. Historical emphasis scores (2015–2024) were modeled using linear regression to project thematic growth through 2035. Each theme was rated for system readiness based on stakeholder insight and national preparedness indicators. Results: Ten core themes emerged: Workforce Shortages/Accessibility, Digital Health/Technology, Competency‐Based Education (CBE), Public Health/Prevention, Medication Safety/Optimization, Interprofessional Collaboration, Patient‐Centered Care, Leadership/Advocacy, Professional Identity/Perception, and Business/Financial Acumen. Convergent themes like Workforce Shortages, Public Health, and Medication Safety were validated by national forecasts and reflected high stakeholder urgency. Digital Health and CBE showed the steepest forecasted growth slopes but were marked by low readiness. A strategic prioritization matrix was developed to guide policy and curricular responses based on urgency, growth, and readiness. Conclusions: This study offers a novel, future‐facing framework to guide the transformation of pharmacy education and workforce strategy. High‐priority, low‐readiness themes require urgent investment. Strategic scaffolds such as leadership, identity, and business acumen, though underemphasized, are critical to sustaining innovation. Pharmacy must reimagine itself as a lifelong, adaptable profession, equipped not only to respond to change but to lead it.
- 28 January 2026
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 9 (2) , e70177
Future‐Proofing Pharmacy: A Stakeholder‐Informed Forecast of Workforce and Education Needs
Background: Pharmacy education and workforce development are undergoing significant disruption. While national forecasts outline key directions, they lack granularity and stakeholder validation. This study aimed to develop a stakeholder‐informed, data‐driven forecast of pharmacy strategic priorities through 2035. Objectives were: (1) identify key themes shaping pharmacy's future, (2) align these themes with national priorities, and (3) forecast their trajectory and readiness to inform strategic planning. Methods: A mixed‐methods design integrated qualitative analysis of 27 stakeholder focus groups and eight interviews with trend modeling and policy triangulation. Participants ( n = 148) represented students, faculty, preceptors, administrators, professional organizations, payors, interprofessional educators, and transformation leaders. Transcripts were coded using grounded theory and analyzed for themes. Identified themes were aligned with the 2024 American Association of Colleges of Pharmacy and 2024 American Society of Health‐System Pharmacy Forecast reports. Historical emphasis scores (2015–2024) were modeled using linear regression to project thematic growth through 2035. Each theme was rated for system readiness based on stakeholder insight and national preparedness indicators. Results: Ten core themes emerged: Workforce Shortages/Accessibility, Digital Health/Technology, Competency‐Based Education (CBE), Public Health/Prevention, Medication Safety/Optimization, Interprofessional Collaboration, Patient‐Centered Care, Leadership/Advocacy, Professional Identity/Perception, and Business/Financial Acumen. Convergent themes like Workforce Shortages, Public Health, and Medication Safety were validated by national forecasts and reflected high stakeholder urgency. Digital Health and CBE showed the steepest forecasted growth slopes but were marked by low readiness. A strategic prioritization matrix was developed to guide policy and curricular responses based on urgency, growth, and readiness. Conclusions: This study offers a novel, future‐facing framework to guide the transformation of pharmacy education and workforce strategy. High‐priority, low‐readiness themes require urgent investment. Strategic scaffolds such as leadership, identity, and business acumen, though underemphasized, are critical to sustaining innovation. Pharmacy must reimagine itself as a lifelong, adaptable profession, equipped not only to respond to change but to lead it.
- 23 December 2025
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (2) , 103013
A unifying vision for pharmacy: Defining professional identity through stakeholder perspectives
- 23 December 2025
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (2) , 103013
A unifying vision for pharmacy: Defining professional identity through stakeholder perspectives
- 21 November 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (1) , 101899
The Hidden Architecture of Inertia: Stakeholder Perspectives on the Most Pressing Challenges in Pharmacy Education
- 21 November 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (1) , 101899
The Hidden Architecture of Inertia: Stakeholder Perspectives on the Most Pressing Challenges in Pharmacy Education
- 20 November 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (1) , 101900
From Strength to Struggle: Stakeholder Insights into the Readiness of Tomorrow’s Pharmacists
- 20 November 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (1) , 101900
From Strength to Struggle: Stakeholder Insights into the Readiness of Tomorrow’s Pharmacists
- 2 July 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 89 (8) , 101458
Pharmacy Is an Applied Discipline: The Baumkuchen Layer Model of Curriculum Design
- 2 July 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 89 (8) , 101458
Pharmacy Is an Applied Discipline: The Baumkuchen Layer Model of Curriculum Design
- Open Access
- 13 February 2025
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (4) , 311-316
Impact of artificial intelligence on future clinical pharmacy research and scholarship
Almost every facet of modern biomedical research involves artificial intelligence (AI). This ACCP commentary forecasts the role of AI in clinical pharmacy research and scholarship. The potential benefits/opportunities together with the limitations/challenges of AI are reviewed for stages of the scientific method including (1) developing the research question(s), study design, and execution; (2) data analysis; and (3) reporting and dissemination of clinical pharmacy research. Benefits and opportunities of AI in clinical pharmacy research include streamlining hypothesis generation and facilitating study design, overcoming limitations of traditional statistical analysis techniques, facilitating manuscript development and dissemination, and expediting peer review. Limitations and challenges of AI include the introduction of biases in subject recruitment; generation of false information, also known as “AI hallucinations”; concern of “black box” analyses that are difficult to validate; potential legal liabilities; lack of accountability; and the need for investigators to ensure the accuracy and integrity of AI‐generated content. In summary, rapid progress of AI capabilities has great potential to revolutionize and accelerate clinical pharmacy research and scholarship; however, it is also imperative to recognize and mitigate the challenges and limitations introduced by AI.
- 13 February 2025
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (4) , 311-316
Open AccessImpact of artificial intelligence on future clinical pharmacy research and scholarship
Almost every facet of modern biomedical research involves artificial intelligence (AI). This ACCP commentary forecasts the role of AI in clinical pharmacy research and scholarship. The potential benefits/opportunities together with the limitations/challenges of AI are reviewed for stages of the scientific method including (1) developing the research question(s), study design, and execution; (2) data analysis; and (3) reporting and dissemination of clinical pharmacy research. Benefits and opportunities of AI in clinical pharmacy research include streamlining hypothesis generation and facilitating study design, overcoming limitations of traditional statistical analysis techniques, facilitating manuscript development and dissemination, and expediting peer review. Limitations and challenges of AI include the introduction of biases in subject recruitment; generation of false information, also known as “AI hallucinations”; concern of “black box” analyses that are difficult to validate; potential legal liabilities; lack of accountability; and the need for investigators to ensure the accuracy and integrity of AI‐generated content. In summary, rapid progress of AI capabilities has great potential to revolutionize and accelerate clinical pharmacy research and scholarship; however, it is also imperative to recognize and mitigate the challenges and limitations introduced by AI.